Repligen Reports First Quarter 2021 Financial ResultsĀ and Updates Full Year 2021 Financial Guidance

Go back to Repligen Reports First Quarter 2021 Financial ResultsĀ and Updates Full Year 2021 Financial Guidance

Repligen (RGEN) Tops Q1 EPS by 26c

May 4, 2021 7:33 AM EDT

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.68, $0.26 better than the analyst estimate of $0.42. Revenue for the quarter came in at $142.8 million versus the consensus estimate of $117.01 million.

Tony J. Hunt, President and Chief Executive Officer said, I am extremely proud... More